The aim of this study was to investigate the correlation between the expression of hypoxia-inducible factor 1 alpha (HIF-1 alpha) and proliferative activity in tumor cells, lymph node metastasis, as well as prognosis in patients with oral squamous cell carcinoma (OSCC). Fifty-seven biopsy specimens of OSCC were investigated for the expression of HIF-1 alpha and proliferating cell nuclear antigen (PCNA) by immunohistochemistry. None of the patients had received any prior treatments. The percentage of HIF-1 alpha immunopositive area (PHIA) was calculated using computer-assisted image analysis for quantitative assessment of HIF-1 alpha expression.
Introduction
Hypoxia causes cell death if it is severe or prolonged. However, cancer cells acclimatize to this hostile environment. Hypoxia induces many kinds of growth factor and protein, including erythropoietin 1 , vascular endothelial growth factor (VEGF) 2 , endothelin 3 , platelet-derived growth factor (PDGF) 4 , and b-FGF 5 . Their effects are responsible for tumor cell survival in the hypoxic condition, and overexpression of these growth factors and proteins in cancer cells is likely to induce poor prognosis [6] [7] [8] [9] [10] .
Hypoxia-inducible factor 1 (HIF-1) alpha is a bHLH-PAS transcription factor that plays an essential role in O 2 homeostasis [11] [12] [13] . The HIF-1 alpha transcription factor mediates transcriptional responses to hypoxia by binding to hypoxia-responsive elements (HRE) present within target genes, such as those encoding growth factors and proteins induced by hypoxia 14, 15 . Accordingly, it is speculated that HIF-1 alpha expression plays an important role in the prognosis of cancer patients. Indeed, there were many reports concerning the correlation between expression of HIF-1 alpha in cancer cells and patient mortality [16] [17] [18] [19] [20] [21] . However, few studies have reported the correlation between the expression of HIF-1 alpha and prognosis in patient with oral squamous cell carcinoma (OSSC) 22 .
On the other hand, there have been some reports investigating the correlation between proliferative activity of tumor cells and prognosis in patients with OSCC 23-25 .
However, the correlation between HIF-1 alpha expression and tumor proliferative activity in OSCC is still not clearly understood. Because proliferating cell nuclear antigen (PCNA) synthesis occurs in the latter part of the G1 phase and throughout the S phase, while this protein is virtually undetectable in M-phase cells 26 , PCNA is a reliable marker to assess the proliferative activity of cells. The aim of the present study was to elucidate the correlation between the expression of HIF-1 alpha and prognosis as well as tumor cell proliferative activity in patients with OSCC using HIF-1 alpha and PCNA immunohistochemistry.
Materials and Methods

Patients and tumor samples
Biopsy specimens of OSCC were obtained with informed consent from 57 patients at the Nagasaki University Hospital of Medicine and Dentistry. All patients were staged according to the tumor-node-metastasis (TNM) classification of tumors (International Union Against Cancer (UICC)). Ten patients had stage I, 15 patients had stage II, 8
patients had stage III, and 24 patients had stage IV. All patients were fresh cases and had not received any previous treatment. The follow-up period of the disease was from 4 to 16 years after treatment. In our study, good prognosis was defined as patients who were alive without any sign of a tumor, and poor prognosis was defined as patients who died during the observation period as a result of their tumors.
HIF-1 alpha and PCNA immunohistochemistry
All the specimens obtained from biopsy were fixed in 3.7% neutral formalin for 24 h.
Processing for routine paraffin embedding followed, and 4.0-µm sections were prepared, mounted on poly L-lysine-coated glass slides, and dried overnight on a hotplate at 37 ˚C to promote adhesion. Immunohistochemical staining was performed using the avidin-biotin complex method as described herein.
In the first and second sections, HIF-1 alpha and PCNA immunohistochemical staining were performed, respectively. Anti-HIF-1 alpha monoclonal mouse antibody Immunohistological sections were photographed using a Nikon digital camera, Coolpix 4500 (Nikon Co., Tokyo, Japan), at a 50 x magnification. After saving the captured image in a personal computer, the image was cropped to a 256 x 256 pixel image.
After noise reduction treatment and edge enhancement, image analysis was performed Labeled and unlabeled cells were counted with the aid of a squared eyepiece graticule (Nikon, Tokyo, Japan) at a magnification of x400.
Statistical analysis
The statistical analysis for prognosis and PHIA and/or PCNA LI was performed using the Mann-Whitney U-test. Furthermore, Pearson's correlation coefficients were determined for PHIAs and PCNA LIs. Data were considered statistically significant if P values were less than or equal to 0.05.
Results
HIF-1 alpha expression and percentage of HIF-1 alpha immunopositive area
HIF-1 alpha expression was found in all specimens. The expression was mainly confirmed by the presence of brown-stained nuclei and/or cytoplasm of tumor cells (Fig.   1 ). Accordingly, the PHIA was calculated to precisely assess the quantification of HIF-1 alpha. The extent, intensity, and distribution of staining seen were heterogeneous, and it was found regularly around areas of necrosis.
Seventeen of the 57 patients had metastatic lymph nodes. The average PHIA was 7.5% in the patients who had no metastatic lymph nodes, while it was 11.7% in the patients who had metastatic lymph nodes. The PHIA of patients who had metastatic lymph nodes was significantly higher than that of patients who had no metastatic lymph nodes ( Fig. 2a; P=0 .0487). Twenty-four of the 57 patients had a poor prognosis in all stages. In the poor prognosis patients, the average PHIA was 12.1%, while it was 6.4% in the good prognosis patients. There was a significant difference in the PHIA values between patients with poor prognosis and those with good prognosis ( Fig. 2b; P=0.0065). In the stage I and II patients, 9 of the 25 patients had a poor prognosis.
The reasons for poor prognosis in these patients included 1 case of local recurrence, 4
cases of delayed lymphatic metastasis, and 4 cases of pulmonary metastasis. The average of PHIA was 8.2% in the good prognosis patients and 11.6% in the poor prognosis patients. There was no significant difference in the PHIA values between poor prognosis patients and good prognosis patients ( Fig. 3a; P=0.9323 ). In the stage III and IV patients, 15 of 32 patients had poor prognosis. The reasons for poor prognosis in these patients included 11 cases of local recurrence, 2 cases of delayed lymphatic metastasis, and 2 cases of pulmonary metastasis. The average of PHIA was 4.6% in the good prognosis patients and 12.3% in the poor prognosis patients. There was a significant difference in PHIA values between the poor prognosis patients and the good prognosis patients ( Fig. 3b; P=0 .0065). Our analysis results demonstrated that PHIA in patients who had metastatic lymph nodes was significantly higher than that in patients who had no metastatic lymph nodes. Tumor metastasis is closely associated with the invasive tumor front, and an infiltrative pattern of invasion shows a greater tendency to metastasize 32, 33 .
PCNA immunohistochemistry and labeling indices
Additionally, the loss of cellular cohesiveness, which results in an infiltrative pattern of invasion, has been attributed to dysfunction of E-cadherin [34] [35] [36] . On the other hand, Imai et al. 37 experimentally showed that E-cadherin expression was remarkably decreased under hypoxia in tumor cells. Therefore, we speculated that hypoxic OSCC cells were responsible for the dysfunction of E-cadherin, inducing lymph node metastasis.
We demonstrated in the present study that HIF1-alpha was expressed at a significantly higher level in poor prognosis patients, especially those in stage III and IV.
Similar results had been reported in studies where HIF-1 alpha expression correlated with poor prognosis and an aggressive index of cancer 16, 22 . Fillies et al. 38 reported that increased HIF-1 alpha expression was associated with good prognosis in early stage squamous cell carcinoma of the oral floor, but they speculated that expression of HIF-1 alpha is not hypoxia related but is due to alterations in oncogene or tumor suppressor genes. Therefore, we investigated the prognosis of patients with OSCC in stage I, II and stage III, IV, respectively, to investigate the different behavior of HIF-1 alpha expression between early stage OSCC and advanced stage OSCC in the present study.
As a result, we demonstrated that HIF-1 alpha expression in stage I, II OSCC was not a prognostic maker. Because poor prognosis in 11 of 15 patients who had stage III or IV cancer resulted from local recurrence, residual tumor cells, which are also closely associated with invasive tumor front 32 , were a critical factor for prognosis. The process of tumor cell invasion involves degradation of the extracellular matrix, and matrix metalloproteinases (MMPs) play an important role in invasion in OSCC [39] [40] [41] .
On the other hand, the authors of one study also pointed out that a hypoxic microenvironment in human OSCC plays important roles in the expression of matrix MMPs 42 . These findings are indicative that hypoxia in OSCC might be responsible for the enhancement of tumor cell invasion as well as metastasis, resulting in poor prognosis.
We observed a weak inverse correlation between PHIA and PCNA LIs, although there was no statistically significant correlation in the present study. This is consistent with the results from other studies that have used combined assays of proliferation and hypoxia [43] [44] [45] [46] . The authors of all of the related studies concur that there is no correlation between overall labeling index of the proliferation markers and measurements of hypoxia. These findings might imply that the overall proliferative activity was independent of overall oxygenation status in OSCC.
In conclusion, expression of HIF1-alpha in OSCC is likely to be of great value to predict the prognosis of OSCC, and could provide important information for a treatment program. 
